174 related articles for article (PubMed ID: 7936652)
61. Reversion of the transformed phenotypes of v-H-ras NIH3T3 cells by flavonoids through attenuating the content of phosphotyrosine.
Kuo ML; Lin JK; Huang TS; Yang NC
Cancer Lett; 1994 Nov; 87(1):91-7. PubMed ID: 7525047
[TBL] [Abstract][Full Text] [Related]
62. Microinjection of the ras oncogene protein into nonestablished rat embryo fibroblasts.
Sullivan NF; Sweet RW; Rosenberg M; Feramisco JR
Cancer Res; 1986 Dec; 46(12 Pt 1):6427-32. PubMed ID: 3536079
[TBL] [Abstract][Full Text] [Related]
63. Suppression of Ras-mediated NIH3T3 transformation by p19ARF does not involve alterations of cell growth properties.
Calabrò V; Parisi T; Di Cristofano A; La Mantia G
Oncogene; 1999 Mar; 18(12):2157-62. PubMed ID: 10321741
[TBL] [Abstract][Full Text] [Related]
64. The antibiotic, L-beta-(5-hydroxy-2-pyridyl)-alanine specifically inhibits growth of the NIH3T3 cells transformed by activated human c-Ha-ras and induces formation of flat revertant cells.
Shindo-Okada N; Nagahara H; Yamaizumi Z; Makabe O; Nishimura S
Nucleic Acids Symp Ser; 1988; (19):129-30. PubMed ID: 3067212
[No Abstract] [Full Text] [Related]
65. Deletion of the COOH terminus converts the ST5 p70 protein from an inhibitor of RAS signaling to an activator with transforming activity in NIH-3T3 cells.
Majidi M; Gutkind JS; Lichy JH
J Biol Chem; 2000 Mar; 275(9):6560-5. PubMed ID: 10692462
[TBL] [Abstract][Full Text] [Related]
66. Tumorigenesis of K-ras mutation in human endometrial carcinoma via upregulation of estrogen receptor.
Tu Z; Gui L; Wang J; Li X; Sun P; Wei L
Gynecol Oncol; 2006 May; 101(2):274-9. PubMed ID: 16303170
[TBL] [Abstract][Full Text] [Related]
67. R-Ras signals through specific integrin alpha cytoplasmic domains to promote migration and invasion of breast epithelial cells.
Keely PJ; Rusyn EV; Cox AD; Parise LV
J Cell Biol; 1999 May; 145(5):1077-88. PubMed ID: 10352023
[TBL] [Abstract][Full Text] [Related]
68. A role for Rho in Ras transformation.
Qiu RG; Chen J; McCormick F; Symons M
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11781-5. PubMed ID: 8524848
[TBL] [Abstract][Full Text] [Related]
69. Activated K-RAS and its effect on morphological appearance.
Kiyokawa E; Minato H
J Biochem; 2014 Sep; 156(3):137-45. PubMed ID: 24958732
[TBL] [Abstract][Full Text] [Related]
70. Apoptosis regulation by Raf, Bcl-2, and R-Ras.
Troppmair J; Rapp UR
Recent Results Cancer Res; 1997; 143():245-9. PubMed ID: 8912424
[No Abstract] [Full Text] [Related]
71. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras.
Nagakubo D; Taira T; Kitaura H; Ikeda M; Tamai K; Iguchi-Ariga SM; Ariga H
Biochem Biophys Res Commun; 1997 Feb; 231(2):509-13. PubMed ID: 9070310
[TBL] [Abstract][Full Text] [Related]
72. Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras.
Stacey DW; Feig LA; Gibbs JB
Mol Cell Biol; 1991 Aug; 11(8):4053-64. PubMed ID: 2072908
[TBL] [Abstract][Full Text] [Related]
73. Biological assays for cellular transformation.
Cox AD; Der CJ
Methods Enzymol; 1994; 238():277-94. PubMed ID: 7799794
[TBL] [Abstract][Full Text] [Related]
74. Analysis of the fibroblast transformation potential of GTPase-deficient gip2 oncogenes.
Gupta SK; Gallego C; Lowndes JM; Pleiman CM; Sable C; Eisfelder BJ; Johnson GL
Mol Cell Biol; 1992 Jan; 12(1):190-7. PubMed ID: 1729598
[TBL] [Abstract][Full Text] [Related]
75. BRCA1 partially reverses the transforming activity of the ras oncogene.
Kumar A; Knott C; Kuus-Reichel K; Saedi MS
Neoplasia; 1999 Nov; 1(5):417-23. PubMed ID: 10933056
[TBL] [Abstract][Full Text] [Related]
76. The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene.
Diaz R; Ahn D; Lopez-Barcons L; Malumbres M; Perez de Castro I; Lue J; Ferrer-Miralles N; Mangues R; Tsong J; Garcia R; Perez-Soler R; Pellicer A
Cancer Res; 2002 Aug; 62(15):4514-8. PubMed ID: 12154063
[TBL] [Abstract][Full Text] [Related]
77. Midkine induces the transformation of NIH3T3 cells.
Kadomatsu K; Hagihara M; Akhter S; Fan QW; Muramatsu H; Muramatsu T
Br J Cancer; 1997; 75(3):354-9. PubMed ID: 9020479
[TBL] [Abstract][Full Text] [Related]
78. Analyses of M-Ras/R-Ras3 signaling and biology.
Quilliam LA; Rebhun JF; Zong H; Castro AF
Methods Enzymol; 2001; 333():187-202. PubMed ID: 11400336
[No Abstract] [Full Text] [Related]
79. The role of wild-type and mutated N-ras in the malignant transformation of liver cells.
Schleger C; Heck R; Steinberg P
Mol Carcinog; 2000 May; 28(1):31-41. PubMed ID: 10820486
[TBL] [Abstract][Full Text] [Related]
80. Wild-type RAS: keeping mutant RAS in CHK.
Anastassiadis T; Brown EJ
Cancer Cell; 2014 Feb; 25(2):137-8. PubMed ID: 24525230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
